C-WTDPProdrome Sciences
plasmalogens, lipid biology, biomarker testing
consumer products
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-WTDP
C-WTDPC-WTDPplasmalogens, lipid biology, biomarker testing
0-100 chain-logic scale · 15 dimensions · scored on public evidence
In the 2021-02-23 homepage snapshot, Prodrome Sciences presents the view that plasmalogen deficiency is a meaningful biological problem tied to neurodegenerative disease and accelerated mortality, and that this condition can be usefully assessed through its ProdromeScan blood test. The company’s visible messaging frames plasmalogens as an important mechanism in health and positions measurement and education around that mechanism as central to its work.
SourceProdrome Sciences states that disease begins with a measurable biochemical prodrome that appears before symptoms, that this prodrome contains the causal basis of later disease, and that medicine should focus on understanding, detecting, and correcting these early biochemical abnormalities to prevent disease, reduce mortality, and maintain optimal health.
SourceProdrome Sciences states that every disease has a prodrome, meaning an early biochemical phase that appears before clinical symptoms, and that disease can be prevented or reduced by discovering, understanding, detecting, and treating these dysfunctional biochemical states before illness becomes clinically apparent. The company frames this as an evidence-based preventive medicine approach aimed at reducing disease prevalence, mortality, and age-related health decline through population-wide monitoring and targeted prevention for high-risk or prodrome-positive individuals.
SourceProdrome Sciences states that every disease has an earlier prodrome phase in which a healthy biochemical system becomes dysfunctional before clinical symptoms appear, and that understanding, detecting, and correcting these prodrome states can prevent disease, reduce mortality, and preserve health at the population level.
SourceProdrome Sciences states that disease has identifiable biochemical prodromes, or early warning signs, that can be measured before full illness develops. The company says its technology reveals biochemical patterns of health and disease that should shift medicine from reacting to symptoms toward proactively detecting prodromes and preventing disease, using blood biomarkers and targeted supplements to address specific molecular deficiencies.
Source